The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression

Biomedicine and Pharmacotherapy

Volumn 82, Issue , 2016, Pages 595-605

  Luo, Cheng lin ^a   Liu, Yu qiong ^b   Wang, Peng ^c   Song, Chun hua ^c   Wang, Kai juan ^c   Dai, Li ping ^c   Zhang, Jian ying ^c   Ye, Hua ^c  

^a UNIVERSITY OF TEXAS AT EL PASO   (United States)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^c ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cell death; Cervical cancer; JAK2; Proliferation; Quercetin nanoparticles

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CYCLIN D1; GOLD NANOPARTICLE; JANUS KINASE 2; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; POLYGLACTIN; QUERCETIN; STAT3 PROTEIN; STAT5 PROTEIN; JAK2 PROTEIN, HUMAN; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER GROWTH; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; CLINICAL ARTICLE; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR XENOGRAFT; UTERINE CERVIX CANCER; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; CHEMISTRY; DISEASE COURSE; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; METABOLISM; NUDE MOUSE; PATHOLOGY; SURVIVAL ANALYSIS; TUMOR CELL LINE; TUMOR INVASION; UTERINE CERVIX TUMOR;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HUMANS; JANUS KINASE 2; MICE, INBRED BALB C; MICE, NUDE; NANOPARTICLES; NEOPLASM INVASIVENESS; QUERCETIN; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84973392600     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.05.029     Document Type: Article

References (41)

1. Lorusso D., Petrelli F., Coinu A., Raspagliesi F., Barni S. A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol. Oncol. 2014, 133:117-123.
2. Adefuye A., Katz A.A., Sales K.J. The regulation of inflammatory pathways and infectious disease of the cervix by seminar fluid. Patholog. Res. Int. 2014, 2014:748740.
3. Xu L., Liu J.H., Zhang J., Zhang N., Wang Z.H. Blockade of autophagy aggravates endoplasmic reticulum stress and improves Paclitaxel cytotoxicity in humancervical cancer cells. Cancer Res. Treat. 2015, 47:313-321.
4. Saxena N.K., Sharma D., Ding X., Lin S., Marra F., Merlin D., Anania F.A. Concomitant activation of the JAK/STAT, PI3 K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007, 67:2497-2507.
5. Xiong H., Zhang Z.G., Tian X.Q., Sun D.F., Liang Q.C., Zhang Y.J., Lu R., Chen Y.X., Fang J.Y. Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 2008, 10:287-297.
6. Bolli R., Stein A.B., Guo Y., Wang O.L., Rokosh G., Dawn B., Molkentin J.D., Sanganalmath S.K., Zhu Y., Xuan Y.T. A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. J. Mol. Cell. Cardiol. 2011, 50:589-597.
7. Elsasser A., Suzuki K., Lorenz-Meyer S., Bode C., Schaper J. The role of apoptosis in myocardial ischemia: a critical appraisal. Basic Res. Cardiol. 2001, 96:219-226.
8. Cargnello M., Tcherkezian J., Roux P.P. The expanding role of mTOR in cancer cell growth and proliferation. Mutagenesis 2015, 30:169-176.
9. Kobori M., Takahashi Y., Sakurai M., Akimoto Y., Tsushida T., Oike H., Ippoushi K. Quercetin suppresses immune cell accumulation and improves mitochondrial gene expression in adipose tissue of diet-induced obese mice. Mol. Nutr. Food Res. 2016, 60:300-312.
10. Stewart L.K., Soileau J.L., Ribnicky D., Wang Z.Q., Raskin I., Poulev A., Majewski M., Cefalu W.T., Gettys T.W. Quercetin transiently increases energy expenditure but persistently decreases circulating markers of inflammation in C57BL/6J mice fed a high-fat diet. Metabolism 2008, 57:S39-S46.
11. Muller K., Fedosov D.A., Gompper G. Margination of micro- and nano-particles in blood flow and its effect on drug delivery. Sci. Rep. 2014, 4.
12. Bhattacharyya S.S., Paul S., De A., Das D., Samadder A., Boujedaini N., Khuda-Bukhsh A.R. Poly (lactideco-glycolide) acid nanoencapsulation of a synthetic coumarin: cytotoxicity and bio-distribution in mice, in cancer cell line and interaction with calf thymus DNA as target. Toxicol. Appl. Pharmacol. 2011, 253:270-282.
13. Maitland M.L., Schilsky R.L. Clinical trials in the era of personalized oncology. CA Cancer J. Clin. 2011, 61:365-381.
14. Minaei A., Sabzichi M., Ramezani F., Hamishehkar H., Samadi N. Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells. Mol. Biol. Rep. 2016, 43:99-105.
15. Wang C., Su L., Wu C., Wu J., Zhu C., Yuan G. RGD peptide targeted lipid coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinoma. Drug. Dev. Ind. Pharm. 2016, 4:1-29.
16. Bishayee K., Khuda-Bukhsh A.R., Huh S.O. PLGA-loaded gold-nanoparticles precipitated with quercetin downregulate HDAC-Akt activities controlling proliferation and activate p 53-ROS crosstalk to induce apoptosis in hepatocarcinoma cells. Mol. Cells 2015, 38:518-527.
17. Sharma G., Park J., Sharma A.R., Jung J.S., Kim H., Chakraborty C., Song D.K., Lee S.S., Nam J.S. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer. Pharm. Res. 2015, 32:723-735.
18. Lee K.M., Hwang M.K., Lee D.E., Lee K.W., Lee H.J. Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells. J. Agric. Food Chem. 2010, 58:5815-5820.
19. Tan J., Wang S., Yang J., Liu Y. Coupled particulate and continuum model for nanoparticle targeted delivery. Comput. Struct. 2013, 122:128-134.
20. Nwankwo K.C., Aniebue U.U., Aguwa E.N., Anarado A.N., Agunwah E. Knowledge attitudes and practices of cervical cancer screening among urban and rural Nigerian women: a call for education and mass screening. Eur. J. Cancer Care (Engl.) 2011, 20:362-367.
21. Bureau G., Longpre F., Martinoli M.G. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J. Neurosci. Res. 2008, 86:403-410.
22. Dong Y.S., Wang J.L., Feng D.Y., Qin H.Z., Wen H., Yin Z.M., Gao G.D., Li C. Protective effect of quercetin against oxidative stress and brain edema in an experimental rat model of subarachnoid hemorrhage. Int. J. Med. Sci. 2014, 11:282-290.
23. Wang S., Zhou Y., Tan J., Xu J., Yang J., Liu Y. Computational modeling of magnetic nanoparticle targeting to stent surface under high gradient field. Comput. Mech. 2014, 53:403-412.
24. Puhl A.C., Fagundes M., dos Santos K.C., Polikarpov I., das Gracas M.F., da Silva F., Fernandes J.B., Vieira P.C., Forim M.R. Preparation and characterization of polymeric nanoparticles loaded with the flavonoid luteolin, by using factorial design. Int. J. Drug Deliv. 2011, 3:683-698.
25. Menet C.J., Rompaey L.V., Geney R. Advances in the discovery of selective JAK inhibitors. Prog. Med. Chem. 2013, 52:153-223.
26. Lim J., Taoka B., Otte R.D., Spencer K., Dinsmore C.J., Altman M.D., Chan G., Rosenstein C., Sharma S., Su H.P., et al. Discovery of 1-amino-5H-pyrido(4,3-b)indol-4-carboxamide inhibitors of janus kinase 2 (JAK2) for the treatment of myeloproliferative disorders. J. Med. Chem. 2011, 54:7334-7349.
27. Fernandez L., Flores-Morales A., Lahuna O., Sliva D., Norstedt G., Haldosen L.A., Mode A., Gustafsson J.A. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C. Endocrinology 1998, 139:1815-1824.
28. Cui Y., Hosui A., Sun R., Shen K., Gavrilova O., Chen W., Cam M.C., Gao B., Robinson G.W., Hennighausen L. Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Hepatology 2007, 46:504-513.
29. Bartoli M., Platt D., Lemtalsi T., Gu X., Brooks S.E., Marrero M.B., Caldwell R.B. VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J. 2003, 17:1562-1564.
30. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 2009, 9:798-809.
31. Real P.J., Sierra A., de Juan A., Segovia J.C., Lopez-Vega J.M., Fernandez-Luna J.L. Resistance to chemotherapy via STAT3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 2002, 21:7611-7618.
32. Longo P.G., Laurenti L., Gobessi S., Sica S., Leone G., Efremov D.G. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood 2008, 111:846-855.
33. Guillermet-Guibert J., Bjorklof K., Salpekar A., Gonella C., Ramadani F., Bilancio A., Meek S., Smith A.J., Okkenhaug K., Vanhaesebroeck B. The p110beta isoform of phosphoinositide 3-kinase signals downstream of g protein-coupled receptors and is functionally redundant with p110gamma. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:8292-8297.
34. Maurer U., Preiss F., Brauns-Schubert P., Schlicher L., Charvet C. GSK-3-at the crossroads of cell death and survival. J. Cell Sci. 2014, 127:1369-1378.
35. Tan J., Geng L., Yazlovitskaya E.M., Hallahan D.E. Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3β in irradiated vascular endothelium. Cancer Res. 2006, 66:2320-2327.
36. Gartel A.L., Tyner A.L. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther. 2002, 1:639-649.
37. Jonassen A.K., Sack M.N., Mjos O.D., Yellon D.M. Myocardial protection by insulin at reperfusion requires early administration and is mediated via AKT and p70s6 kinase cell-survival signaling. Circ. Res. 2001, 89:1191-1198.
38. Sheng Z., Ma L., Sun J.E., Zhu L.J., Green M.R. BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription. Blood 2011, 118:2840-2848.
39. Burchert A., Wang Y., Cai D., von Bubnoff N., Paschka P., Müller-Brüsselbach S., Ottmann O.G., Duyster J., Hochhaus A., Neubauer A. Compensatory PI3-kinase/Akt/ mTor activation regulates imatinib resistance development. Leukemia 2005, 19:1774-1782.
40. Zhen Y., Li W. Impairment of autophagosome-lysosome fusion in the buff mutant mice with the VPS33A mutation. Autophagy 2015, 11:1608-1622.
41. Bernard A., Klionsky D.J. Toward an understanding of autophagosome-lysosome fusion: the unsuspected role of Atg14. Autophagy 2015, 11:583-584.